← Evidence map

ArticleTherapeutic advances in neurological disorders2021

Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study.

Annette Wundes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 33796143